US Stock MarketDetailed Quotes

SBHMY SINO BIOPHARMACEUT

Watchlist
  • 7.200
  • 0.0000.00%
15min DelayClose Apr 25 16:00 ET
6.76BMarket Cap20.69P/E (TTM)

SINO BIOPHARMACEUT Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
(Q3)Sep 30, 2020
(Q2)Jun 30, 2020
(Q1)Mar 31, 2020
Total revenue
0.67%26.2B
-3.11%26.03B
13.59%26.86B
10.66%7.11B
16.41%7.24B
-2.42%23.65B
12.38%5.52B
-19.36%5.48B
1.69%6.43B
0.22%6.22B
Operating revenue
0.67%26.2B
-3.11%26.03B
13.59%26.86B
10.66%7.11B
16.41%7.24B
-2.42%23.65B
12.38%5.52B
-19.36%5.48B
1.69%6.43B
0.22%6.22B
Cost of revenue
11.19%4.99B
-15.84%4.49B
2.89%5.33B
-12.31%1.34B
11.75%1.42B
5.20%5.18B
-4.10%1.11B
-2.77%1.28B
23.08%1.53B
4.45%1.27B
Gross profit
-1.53%21.21B
0.04%21.54B
16.60%21.53B
17.81%5.77B
17.60%5.83B
-4.37%18.46B
17.44%4.41B
-23.36%4.2B
-3.53%4.9B
-0.80%4.96B
Operating expense
-3.95%15.42B
-6.50%16.06B
21.29%17.18B
15.27%3.98B
16.97%4.57B
0.36%14.16B
33.51%3.66B
-16.40%3.14B
-7.86%3.46B
32.00%3.9B
Selling and administrative expenses
-5.48%11.07B
-7.83%11.71B
9.25%12.7B
20.32%3.29B
19.44%3.5B
-1.43%11.63B
19.58%2.97B
-10.42%2.99B
-9.04%2.73B
-1.17%2.93B
-Selling and marketing expense
-6.28%9.19B
-6.74%9.81B
17.23%10.52B
23.12%2.61B
22.58%3.05B
-3.72%8.97B
22.44%2.11B
-15.45%2.25B
-14.43%2.12B
1.47%2.49B
-General and administrative expense
-1.38%1.87B
-13.08%1.9B
-17.72%2.19B
10.65%678.3M
1.69%448.06M
7.21%2.66B
13.11%862.62M
9.38%739.67M
16.29%613.04M
-13.85%440.6M
Research and development costs
5.73%4.4B
--4.16B
----
----
4.18%1.01B
----
----
----
----
--973.82M
Other operating expenses
0.62%300.69M
-93.55%298.82M
69.25%4.63B
0.79%1.72B
525.52%69.01M
6.77%2.74B
83.69%863.76M
-63.37%158.28M
124.40%1.7B
--11.03M
Operating profit
5.58%5.79B
25.87%5.48B
1.15%4.35B
23.87%1.79B
19.94%1.26B
-17.20%4.3B
-25.79%755.64M
-38.61%1.05B
8.70%1.44B
-48.43%1.05B
Net non-operating interest income expense
-32.10%-308.56M
-59.38%-233.59M
-13.29%-146.56M
-259.72%-30.3M
-34.16%-17.62M
-566.03%-129.37M
-1,472.08%-71.16M
-361.84%-36.66M
-1,132.11%-8.42M
-269.27%-13.13M
Non-operating interest income
-4.71%186.68M
20.89%195.91M
-16.47%162.06M
-40.02%45.27M
-30.08%54.04M
-24.72%194M
-113.01%-13.25M
-10.78%54.48M
45.31%75.47M
80.33%77.3M
Non-operating interest expense
15.31%495.24M
39.17%429.49M
-4.56%308.62M
-9.93%75.56M
-20.76%71.66M
40.63%323.37M
-40.09%57.91M
93.64%91.14M
64.10%83.89M
157.59%90.43M
Other net income (expense)
Special income (charges)
-156.31%-47.04M
612.71%83.54M
-455.76%-16.29M
488.15%794K
387.21%1.07M
407.20%4.58M
127.34%4.12M
-99.32%108K
--135K
--219K
-Less：Restructuring and merger&acquisition
81.55%-16.54M
-846.23%-89.67M
--12.02M
----
----
----
----
----
----
----
-Less:Other special charges
937.99%63.59M
43.20%6.13M
193.41%4.28M
-488.15%-794K
-387.21%-1.07M
-407.20%-4.58M
-127.34%-4.12M
---108K
---135K
---219K
Other non- operating income (expenses)
69.96%176.58M
-68.16%103.89M
385.63%326.33M
-29.32%22.74M
156.28%49.87M
37.33%67.2M
-13.85%-8.73M
67.36%24.3M
14.08%32.17M
102.19%19.46M
Income before tax
3.74%5.41B
-71.92%5.21B
270.49%18.57B
517.66%8.14B
119.74%2.84B
-11.91%5.01B
5.57%1.27B
-38.98%1.13B
-5.49%1.32B
4.32%1.29B
Income tax
14.43%797.27M
-64.41%696.72M
191.19%1.96B
169.81%889.97M
106.47%446.94M
-25.52%672.38M
-249.41%-105.32M
-39.53%231.37M
38.92%329.86M
2.01%216.47M
Net income
1.89%5.1B
-69.89%5B
282.77%16.61B
633.84%7.25B
122.41%2.39B
-9.34%4.34B
21.40%1.38B
-38.84%898.44M
-14.61%987.57M
4.79%1.08B
Net income continuous Operations
2.09%4.61B
-72.81%4.52B
282.77%16.61B
633.84%7.25B
122.41%2.39B
-9.34%4.34B
21.40%1.38B
-38.84%898.44M
-14.61%987.57M
4.79%1.08B
Net income discontinuous operations
0.06%484.76M
--484.47M
----
----
----
----
----
----
----
----
Minority interest income
12.46%2.77B
22.56%2.46B
27.83%2.01B
9.25%680.35M
139.53%480.92M
-22.54%1.57B
-27.28%457.51M
-56.13%288.55M
9.48%622.74M
17.67%200.77M
Net income attributable to the parent company
-8.32%2.33B
-82.59%2.54B
427.17%14.61B
1,700.00%6.57B
118.49%1.91B
0.35%2.77B
81.93%920.59M
-24.81%609.89M
-37.92%364.83M
2.23%875.79M
Preferred stock dividends
Other preferred stock dividends
-190.89%-211.2M
-51.84%232.37M
482.51M
96.90%-11.24M
-29.52%123.77M
0
0
186.4M
-362.01M
175.62M
Net income attributable to common stockholders
10.04%2.54B
-83.64%2.31B
409.76%14.13B
805.03%6.58B
155.61%1.79B
0.35%2.77B
81.93%920.59M
-47.79%423.49M
23.69%726.84M
-18.27%700.17M
Basic earnings per share
-7.43%2.518
-82.53%2.72
428.02%15.566
1,702.06%6.992
118.67%2.038
0.41%2.948
80.59%0.986
-25.41%0.642
-37.69%0.388
2.79%0.932
Diluted earnings per share
3.62%2.518
-83.42%2.43
397.01%14.652
1,657.73%6.82
151.49%1.856
0.41%2.948
80.59%0.986
-25.41%0.642
-37.69%0.388
-18.60%0.738
Dividend per share
-14.58%1.4873
74.41%1.7411
-15.21%0.9983
36.46%0.6659
0
23.52%1.1773
40.66%0.337
45.40%0.3523
3.56%0.488
0
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020(Q3)Sep 30, 2020(Q2)Jun 30, 2020(Q1)Mar 31, 2020
Total revenue 0.67%26.2B-3.11%26.03B13.59%26.86B10.66%7.11B16.41%7.24B-2.42%23.65B12.38%5.52B-19.36%5.48B1.69%6.43B0.22%6.22B
Operating revenue 0.67%26.2B-3.11%26.03B13.59%26.86B10.66%7.11B16.41%7.24B-2.42%23.65B12.38%5.52B-19.36%5.48B1.69%6.43B0.22%6.22B
Cost of revenue 11.19%4.99B-15.84%4.49B2.89%5.33B-12.31%1.34B11.75%1.42B5.20%5.18B-4.10%1.11B-2.77%1.28B23.08%1.53B4.45%1.27B
Gross profit -1.53%21.21B0.04%21.54B16.60%21.53B17.81%5.77B17.60%5.83B-4.37%18.46B17.44%4.41B-23.36%4.2B-3.53%4.9B-0.80%4.96B
Operating expense -3.95%15.42B-6.50%16.06B21.29%17.18B15.27%3.98B16.97%4.57B0.36%14.16B33.51%3.66B-16.40%3.14B-7.86%3.46B32.00%3.9B
Selling and administrative expenses -5.48%11.07B-7.83%11.71B9.25%12.7B20.32%3.29B19.44%3.5B-1.43%11.63B19.58%2.97B-10.42%2.99B-9.04%2.73B-1.17%2.93B
-Selling and marketing expense -6.28%9.19B-6.74%9.81B17.23%10.52B23.12%2.61B22.58%3.05B-3.72%8.97B22.44%2.11B-15.45%2.25B-14.43%2.12B1.47%2.49B
-General and administrative expense -1.38%1.87B-13.08%1.9B-17.72%2.19B10.65%678.3M1.69%448.06M7.21%2.66B13.11%862.62M9.38%739.67M16.29%613.04M-13.85%440.6M
Research and development costs 5.73%4.4B--4.16B--------4.18%1.01B------------------973.82M
Other operating expenses 0.62%300.69M-93.55%298.82M69.25%4.63B0.79%1.72B525.52%69.01M6.77%2.74B83.69%863.76M-63.37%158.28M124.40%1.7B--11.03M
Operating profit 5.58%5.79B25.87%5.48B1.15%4.35B23.87%1.79B19.94%1.26B-17.20%4.3B-25.79%755.64M-38.61%1.05B8.70%1.44B-48.43%1.05B
Net non-operating interest income expense -32.10%-308.56M-59.38%-233.59M-13.29%-146.56M-259.72%-30.3M-34.16%-17.62M-566.03%-129.37M-1,472.08%-71.16M-361.84%-36.66M-1,132.11%-8.42M-269.27%-13.13M
Non-operating interest income -4.71%186.68M20.89%195.91M-16.47%162.06M-40.02%45.27M-30.08%54.04M-24.72%194M-113.01%-13.25M-10.78%54.48M45.31%75.47M80.33%77.3M
Non-operating interest expense 15.31%495.24M39.17%429.49M-4.56%308.62M-9.93%75.56M-20.76%71.66M40.63%323.37M-40.09%57.91M93.64%91.14M64.10%83.89M157.59%90.43M
Other net income (expense)
Special income (charges) -156.31%-47.04M612.71%83.54M-455.76%-16.29M488.15%794K387.21%1.07M407.20%4.58M127.34%4.12M-99.32%108K--135K--219K
-Less：Restructuring and merger&acquisition 81.55%-16.54M-846.23%-89.67M--12.02M----------------------------
-Less:Other special charges 937.99%63.59M43.20%6.13M193.41%4.28M-488.15%-794K-387.21%-1.07M-407.20%-4.58M-127.34%-4.12M---108K---135K---219K
Other non- operating income (expenses) 69.96%176.58M-68.16%103.89M385.63%326.33M-29.32%22.74M156.28%49.87M37.33%67.2M-13.85%-8.73M67.36%24.3M14.08%32.17M102.19%19.46M
Income before tax 3.74%5.41B-71.92%5.21B270.49%18.57B517.66%8.14B119.74%2.84B-11.91%5.01B5.57%1.27B-38.98%1.13B-5.49%1.32B4.32%1.29B
Income tax 14.43%797.27M-64.41%696.72M191.19%1.96B169.81%889.97M106.47%446.94M-25.52%672.38M-249.41%-105.32M-39.53%231.37M38.92%329.86M2.01%216.47M
Net income 1.89%5.1B-69.89%5B282.77%16.61B633.84%7.25B122.41%2.39B-9.34%4.34B21.40%1.38B-38.84%898.44M-14.61%987.57M4.79%1.08B
Net income continuous Operations 2.09%4.61B-72.81%4.52B282.77%16.61B633.84%7.25B122.41%2.39B-9.34%4.34B21.40%1.38B-38.84%898.44M-14.61%987.57M4.79%1.08B
Net income discontinuous operations 0.06%484.76M--484.47M--------------------------------
Minority interest income 12.46%2.77B22.56%2.46B27.83%2.01B9.25%680.35M139.53%480.92M-22.54%1.57B-27.28%457.51M-56.13%288.55M9.48%622.74M17.67%200.77M
Net income attributable to the parent company -8.32%2.33B-82.59%2.54B427.17%14.61B1,700.00%6.57B118.49%1.91B0.35%2.77B81.93%920.59M-24.81%609.89M-37.92%364.83M2.23%875.79M
Preferred stock dividends
Other preferred stock dividends -190.89%-211.2M-51.84%232.37M482.51M96.90%-11.24M-29.52%123.77M00186.4M-362.01M175.62M
Net income attributable to common stockholders 10.04%2.54B-83.64%2.31B409.76%14.13B805.03%6.58B155.61%1.79B0.35%2.77B81.93%920.59M-47.79%423.49M23.69%726.84M-18.27%700.17M
Basic earnings per share -7.43%2.518-82.53%2.72428.02%15.5661,702.06%6.992118.67%2.0380.41%2.94880.59%0.986-25.41%0.642-37.69%0.3882.79%0.932
Diluted earnings per share 3.62%2.518-83.42%2.43397.01%14.6521,657.73%6.82151.49%1.8560.41%2.94880.59%0.986-25.41%0.642-37.69%0.388-18.60%0.738
Dividend per share -14.58%1.487374.41%1.7411-15.21%0.998336.46%0.6659023.52%1.177340.66%0.33745.40%0.35233.56%0.4880
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg